ATM and neoplasm: Inhibiting the ATM/Chk2 DNA damage checkpoint pathway triggers replication stress and the accumulation of cytosolic DNA, activating the innate immune response mediated by the DNA sensor STING in ARID1A‐deficient tumours.62